Intrinsic resistance to the MEK1/2 inhib
✍
Kathryn Balmanno; Simon D. Chell; Annette S. Gillings; Shaista Hayat; Simon J. C
📂
Article
📅
2009
🏛
John Wiley and Sons
🌐
French
⚖ 466 KB
## Abstract Mutations in __KRAS__ or __BRAF__ frequently manifest in constitutive activation of the MEK1/2‐ERK1/2 signalling pathway. The MEK1/2‐selective inhibitor, AZD6244 (ARRY‐142886), blocks ERK1/2 activation and is currently undergoing clinical evaluation. Tumour cells can vary markedly in th